- Business
- YSB Inc. (9885.HK) is a Cayman Islands-incorporated investment holding company primarily engaged in providing digital pharmaceutical platforms, wholesale and retail of pharmaceuticals and healthcare products, and related SaaS solutions for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system comprising Future Lou point-of-care testing and monitoring devices, Cloud consultation SaaS for digital clinic management, and ClouWiseDoctor AI doctors-aid system; wePharmacy smart unmanned pharmaceutical booths with maintenance services; ClouDiagnos diagnostic testing; YSB eLearn online pharmacist qualification courses; drugstore SaaS including palm store easy versions, Galaxy+ procurement, Xentrum warehousing, IntelNex delivery, and real-sales settlement tools; wholesaler ERP, WMS logistics, and financial systems; as well as clinic and manufacturer SaaS for marketing, promotion, and supply chain services through a nationwide network of 22 strategic warehouses covering over 2,000 counties, 49,100 drugstores, 35,300 grassroots institutions, and 15,000 merchants. Founded in 2015 and headquartered in Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, China, YSB operates principally in the domestic market with 6,763 employees and focuses on outside-hospital pharmaceutical circulation, medical testing, and self-operated businesses that grew 12.5% in the first half of 2025. In late 2024, the company completed the RMB1.035 billion acquisition of 100% equity in Yikuai Pharmaceutical (also referred to as Folding Space Cayman or CSI Healthcare), with RMB420 million cash and RMB615 million in shares issued at HK$12 each including 31.7 million shares on November 26, 2024, to accelerate its proprietary brand expansion; additionally, executives such as CFO Fei Chen increased holdings by 1.3 million shares since April 2025, signaling confidence amid a 258% H1 2025 profit surge.